VEA
RLAY icon

Virtus ETF Advisers’s Relay Therapeutics RLAY Stock Holding History

Virtus ETF Advisers’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,873
Closed -$61.3K – 721
2024
Q4 		$61.3K Buy
14,873
+3,092
+26% +$16.8K 0.03% 443
2024
Q3 		$83.4K Buy
11,781
+212
+2% +$1.58K 0.04% 410
2024
Q2 		$75.4K Buy
11,569
+2,867
+33% +$19.6K 0.04% 423
2024
Q1 		$72.2K Sell
8,702
-593
-6% -$5.79K 0.04% 406
2023
Q4 		$102K Buy
9,295
+1,023
+12% +$8.63K 0.07% 347
2023
Q3 		$69.6K Sell
8,272
-820
-9% -$8.82K 0.04% 386
2023
Q2 		$114K Buy
9,092
+3,306
+57% +$41.1K 0.07% 334
2023
Q1 		$95.3K Sell
5,786
-2,218
-28% -$39.8K 0.05% 347
2022
Q4 		$120K Buy
8,004
+478
+6% +$9.15K 0.06% 419
2022
Q3 		$168K Buy
7,526
+50
+0.7% +$1.1K 0.07% 339
2022
Q2 		$125K Buy
7,476
+1,918
+35% +$41.1K 0.05% 374
2022
Q1 		$166K Sell
5,558
-327
-6% -$7.93K 0.07% 212
2021
Q4 		$181K Sell
5,885
-328
-5% -$10.4K 0.07% 245
2021
Q3 		$196K Sell
6,213
-331
-5% -$11.1K 0.09% 277
2021
Q2 		$239K Sell
6,544
-305
-4% -$10.1K 0.1% 225
2021
Q1 		$237K Buy
6,849
+117
+2% +$5.08K 0.1% 298
2020
Q4 		$280K Buy
+6,732
New +$304K 0.12% 245

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Virtus ETF Advisers's RLAY Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Relay Therapeutics (RLAY) in Q1 2025, closing a stake of 14,873 shares — an estimated $61.3K sold.

Virtus ETF Advisers first reported a position in RLAY in Q4 2020 and held it in 17 quarters. The position peaked at $280K in Q4 2020. 207 funds tracked by Wall St. Rank hold RLAY as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Relay Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 14,873 Relay Therapeutics shares in Q1 2025, an estimated $61.3K.
  • Virtus ETF Advisers first reported a position in Relay Therapeutics in Q4 2020 and held it in 17 quarters.
  • Virtus ETF Advisers's Relay Therapeutics position peaked at $280K in Q4 2020.
  • 207 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.